209219-38-5

Basic information

• Product Name: Z-360
• Synonyms: Nastorazepide;Nastorazepide (Z-360);3-[[[[(3R)-5-Cyclohexyl-1-(3,3-dimethyl-2-oxobutyl)-2,3,4,5-tetrahydro-2-oxo-1H-1,5-benzodiazepin-3-yl]amino]carbonyl]amino]benzoic acid;Nastorazepide Calcium
• CAS NO: 209219-38-5
• Molecular Formula: C29H36N4O5
• Molecular Weight: 520.61994
• Mol File: 209219-38-5.mol
• Article Data: 6

Chemical Properties

• Boiling Point: 742.8±60.0 °C(Predicted)
• Appearance: /
• Density: 1.29±0.1 g/cm3(Predicted)
• PKA: 4.16±0.10(Predicted)
• CAS DataBase Reference: Z-360(CAS DataBase Reference)
• NIST Chemistry Reference: Z-360(209219-38-5)
• EPA Substance Registry System: Z-360(209219-38-5)

Safety Data

• Hazardous Substances Data: 209219-38-5(Hazardous Substances Data)

Usage

General Description

Z-360 is a type of organosilane chemical that is commonly used as a surface treatment and adhesion promoter in various industrial and manufacturing processes. It contains a mixture of functional groups including epoxy, vinyl, and amino, which allows it to chemically bond to a wide range of substrates. Z-360 is known for its ability to enhance the adhesion and durability of coatings, sealants, and adhesives on difficult-to-bond surfaces such as metal, glass, and plastics. It also provides excellent water and chemical resistance, making it a popular choice for applications in the automotive, aerospace, and construction industries. Additionally, Z-360 is compatible with a variety of resins and can improve the overall performance and longevity of bonded materials.

Upstream product

• 343326-73-8 (R)-(-)-1-tert-butylcarbonylmethyl-2-oxo-3-phenoxycarbonylamino-5-cyclohexyl-1,3,4,5-tetrahydro-2H-1,5-benzodiazepine 
• 17264-94-7 sodium m-aminobenzoate 
• 112926-00-8 silica gel 
• 5469-26-1 1-Bromopinacolon 
• 22564-47-2 3-phenyloxycarbonylaminobenzoic acid 
• 92146-82-2 tert-butyl 3-aminobenzoate 
• 209223-35-8 (R)-(-)-2-oxo-3-amino-5-cyclohexyl-1,3,4,5-tetrahydro-2H-1,5-benzodiazepine 
• 209223-73-4 (R)-1-tert-butylcarbonylmethyl-2-oxo-3-tert-butoxycarbonylamino-5-cyclohexyl-1,3,4,5-tetrahydro-2H-1,5-benzodiazepine 
• 209223-33-6 (R)-(+)-2-oxo-3-tert-butoxycarbonylamino-1,3,4,5-tetrahydro-2H-1,5-benzodiazepine 
• 209223-32-5 (R)-(-)-2-tert-butoxycarbonylamino-3-(2-nitrophenylamino)propionic acid 
• 1493-27-2 ortho-nitrofluorobenzene 
• 99-05-8 meta-aminobenzoic acid 
• 343326-72-7 (R)-(-)-1-tert-butylcarbonylmethyl-2-oxo-3-amino-5-cyclohexyl-1,3,4,5-tetrahydro-2H-1,5-benzodiazepine oxalate 
• 252209-91-9 (R)-(-)-2-oxo-3-tert-butoxycarbonylamino-5-cyclohexyl-1,3,4,5-tetrahydro-2H-1,5-benzodiazepine 

Relevant articles and documents

CHOLECYSTOKININ 2 RECEPTOR TARGETED NIR IMAGING AND USE THEREOF

Compounds are described herein where CCK2R targeting ligands are attached to an imaging agent through a linker. The compounds can be used in the detection, diagnosis, imaging and treatment of cancer.

CHOLECYSTOKININ B RECEPTOR TARGETING FOR IMAGING AND THERAPY

Conjugates are described herein where CCK2R targeting ligands are attached to an active moiety, such as therapeutic agent or an imaging agent, through a linker. The conjugates can be used in the detection, diagnosis, imaging and treatment of cancer.

Calcium salts of 1,5-benzodiazepine derivatives, process for producing the salts and drugs containing the same

Provided are calcium salts of a 1,5-benzodiazepine derivative represented by the following formula (I): (wherein, R1 represents a lower alkyl group, R2 represents a phenyl or cyclohexyl group, and Y represents a single bond or a lowe